The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment–driven intervention study
Reena Jayani(Vanderbilt University Medical Center), William Dale(City of Hope), Warren D. Taylor(Duke University), Simone Fernandes Dos Santos Hughes(City of Hope), Daneng Li(City Of Hope National Medical Center), Can‐Lan Sun(University of Minnesota), Vani Katheria(City of Hope), Leana Cabrera Chien(City of Hope), Jeanine Moreno(City of Hope), Anahid Hamparsumian(Geriatric Research Education and Clinical Center)
Cited by 7
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
|JAMA Oncology|2021|464
Communication With Older Patients With Cancer Using Geriatric Assessment
|JAMA Oncology|2019|293
Support for the Vascular Depression Hypothesis in Late-Life Depression
|Archives of General Psychiatry|2010|289